Werewolf Therapeutics, Inc. (HOWL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:09PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 217.28M |
| Enterprise Value | 129.36M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.51 |
| Price/Book (mrq) | 1.85 |
| Enterprise Value/Revenue | 7.97 |
| Enterprise Value/EBITDA | 0.57 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.71 |
| 52-Week Change 3 | 89.39% |
| S&P500 52-Week Change 3 | 29.31% |
| 52 Week High 3 | 8.1940 |
| 52 Week Low 3 | 1.5740 |
| 50-Day Moving Average 3 | 5.7838 |
| 200-Day Moving Average 3 | 4.1213 |
Share Statistics
| Avg Vol (3 month) 3 | 185.74k |
| Avg Vol (10 day) 3 | 170k |
| Shares Outstanding 5 | 43.46M |
| Implied Shares Outstanding 6 | 43.46M |
| Float 8 | 21.73M |
| % Held by Insiders 1 | 6.27% |
| % Held by Institutions 1 | 74.37% |
| Shares Short (Apr 30, 2024) 4 | 414.49k |
| Short Ratio (Apr 30, 2024) 4 | 2.21 |
| Short % of Float (Apr 30, 2024) 4 | 1.63% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.95% |
| Shares Short (prior month Mar 28, 2024) 4 | 472.01k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -256.33% |
| Operating Margin (ttm) | -2,312.94% |
Management Effectiveness
| Return on Assets (ttm) | -15.24% |
| Return on Equity (ttm) | -34.84% |
Income Statement
| Revenue (ttm) | 16.22M |
| Revenue Per Share (ttm) | 0.43 |
| Quarterly Revenue Growth (yoy) | -83.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -43.64M |
| Net Income Avi to Common (ttm) | -41.58M |
| Diluted EPS (ttm) | -1.1000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 139.19M |
| Total Cash Per Share (mrq) | 3.2 |
| Total Debt (mrq) | 51.27M |
| Total Debt/Equity (mrq) | 43.60% |
| Current Ratio (mrq) | 6.71 |
| Book Value Per Share (mrq) | 2.72 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38.01M |
| Levered Free Cash Flow (ttm) | -27.25M |
© 2024 Yahoo. All rights reserved.